Skip to main content
Year archive

Lee's Pharmaceutical Holdings Limited — 2025 filings

All 37 regulatory filings released by Lee's Pharmaceutical Holdings Limited (950) in 2025, sourced directly from the official regulator.

37 Filings
2025 Period
2025 filings (37)
Filing Released Lang
Supplemental Announcement in Relation to Discloseable Transaction - Acquisition of Assets
M&A Activity
2025-12-22 English
Passing Away of Michele Dalla Libera
Board/Management Information
2025-12-18 English
Discloseable Transaction - Acquisition of Assets
M&A Activity
2025-12-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Regulatory Filings
2025-12-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings
2025-11-03 English
Grant of Share Options
Share Issue/Capital Change
2025-10-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Regulatory Filings
2025-10-02 English
Notification Letter and Reply Form to Non-Registered Shareholders - Notice of Publication of Interim Report
Report Publication Announcement
2025-09-19 English
Notification Letter and Reply Form to Registered Shareholders - Notice of Publication of Interim Report
Report Publication Announcement
2025-09-19 English
Interim Report 2025
Interim / Quarterly Report H1 2025
2025-09-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings
2025-09-01 English
Terms of Reference of the Nomination Committee
Governance Information
2025-08-29 English
Interim Dividend for the Six Months Ended 30 June 2025
Notice of Dividend Amount
2025-08-26 English
Interim Results for the Six Months Ended 30 June 2025
Interim / Quarterly Report H2 2025
2025-08-26 English
Notice of Board Meeting
Regulatory Filings
2025-08-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Regulatory Filings
2025-08-04 English
Voluntary Announcement - Update on an Investigational Oncology Drug Product
Regulatory Filings
2025-07-31 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Share Issue/Capital Change
2025-07-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings
2025-06-02 English
Annual General Meeting Held on 22 May 2025 - Poll Results
Declaration of Voting Results & Voting Rights Announcements
2025-05-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings
2025-05-06 English
Notification Letter to Non-registered Shareholders and Reply Form
Report Publication Announcement
2025-04-24 English
Notification Letter to Registered Shareholders and Reply Form
Report Publication Announcement
2025-04-24 English
Proxy Form
Proxy Solicitation & Information Statement
2025-04-23 English
Notice of Annual General Meeting
AGM Information
2025-04-23 English
General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors and Notice of Annual General Meeting
Proxy Solicitation & Information Statement
2025-04-23 English
Environmental, Social and Governance Report 2024
Environmental & Social Information
2025-04-23 English
Annual Report 2024
Annual Report FY 2024
2025-04-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Share Issue/Capital Change
2025-04-01 English
Final Dividend for the Year Ended 31 December 2024
Notice of Dividend Amount
2025-03-27 English
Announcement of Annual Results for the Year Ended 31 December 2024
Annual Report FY 2024
2025-03-27 English
Positive Profit Alert
Earnings Release FY 2024
2025-03-19 English
Notice of Board Meeting
Regulatory Filings
2025-03-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Regulatory Filings
2025-03-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Share Issue/Capital Change
2025-02-03 English
Supplemental Announcement - Inside Information - Land Resumption
Regulatory Filings
2025-01-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings
2025-01-02 English